Panacea Life Sciences Holdings, Inc. (PLSH)

PLSH Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.11	0.1	0.01	0.02	0.08	8.52
Short-Term Investments	0.01	0.01	1.11	3.79	2.85	1.43
Cash & Short-Term Investments	0.12	0.12	1.11	3.81	2.94	9.94
Cash Growth	-88.27%	-89.60%	-70.76%	29.73%	-70.45%	-
Accounts Receivable	0.27	0.26	0.21	0.24	0.15	0.3
Other Receivables	-	-	0.5	0.5	-	-
Receivables	0.27	0.26	0.71	0.74	0.15	0.3
Inventory	4.06	4.01	4.45	4.26	8.41	3.36
Prepaid Expenses	0.19	0.26	0.11	0.28	0.03	0.99
Total Current Assets	4.64	4.66	6.38	9.1	11.52	14.59
Property, Plant & Equipment	9.76	10.31	10.92	12.44	17.53	14.86
Goodwill	3.01	3.01	2.19	2.19	2.19	2.19
Other Intangible Assets	-	-	-	0.06	0.12	0.18
Total Assets	17.41	17.98	19.49	23.78	31.36	31.82

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	5.18	4.63	2.67	1.69	1.77	1.11
Short-Term Debt	0.39	0.51	0.45	0.32	0.27	-
Current Portion of Long-Term Debt	11.77	11.4	9.87	6.44	15.06	13.16
Current Portion of Leases	3.06	2.91	2.09	1.62	1.16	0.71
Total Current Liabilities	20.39	19.45	15.07	10.07	18.26	14.97
Long-Term Debt	3.57	3.57	3.57	3.26	2.7	0.89
Long-Term Leases	3.07	3.25	2.99	3.35	3.69	4.02
Total Liabilities	27.04	26.27	21.63	16.68	24.65	19.88

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	0	0	0	0	0	0.19
Additional Paid-In Capital	25.74	25.63	23.76	23.87	18.69	18.45
Retained Earnings	-35.37	-33.92	-25.91	-16.77	-11.98	-6.75
Total Common Equity	-9.62	-8.29	-2.15	7.1	6.71	11.89
Shareholders' Equity	-9.62	-8.29	-2.14	7.1	6.71	11.94
Total Liabilities & Equity	17.41	17.98	19.49	23.78	31.36	31.82

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	21.86	21.65	18.97	15	22.89	18.77
Net Cash (Debt)	-21.74	-21.53	-17.85	-11.18	-19.95	-8.83
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.28	-1.29	-1.20	-0.63	-1.18	-0.50
Filing Date Shares Outstanding	17.65	17.65	14.76	14.76	18.63	17.79
Total Common Shares Outstanding	18.31	17.65	14.97	14.07	18.63	17.79
Working Capital	-15.75	-14.79	-8.69	-0.97	-6.74	-0.38
Book Value Per Share	-0.53	-0.47	-0.14	0.50	0.36	0.67
Tangible Book Value	-12.64	-11.31	-4.33	4.85	4.4	9.51
Tangible Book Value Per Share	-0.69	-0.64	-0.29	0.34	0.24	0.53
Land	0.09	0.09	0.09	0.09	2.29	2.15
Machinery	11.79	11.78	11.6	11.1	11.54	7.77
Construction In Progress	-	-	-	-	0.74	-
Leasehold Improvements	1.81	1.81	1.51	1.51	1.51	1.55

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 23, 2026

Data Sources Report a data error